Uppsala Universitet
Welcome,         Profile    Billing    Logout  
 1 Trial 
7 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Carlson, Kristina
NCT04067180: Randomized Clinical Study Assessing Haplo vs. URD in AML

Terminated
N/A
18
Europe, Canada, RoW
allogeneic stem cell transplantation with a haplo-identical family donor graft, allogeneic stem cell transplantation with a matched unrelated donor graft
Karolinska Institutet, Skane University Hospital, Uppsala University Hospital, University Hospital, Linkoeping, University Hospital, Umeå, Sahlgrenska University Hospital, Sweden, Oslo University Hospital, St. Petersburg State Pavlov Medical University, Princess Margaret Hospital, Canada, Medical University of Vienna
Acute Myeloid Leukemia
08/22
08/22
NCT06245629: Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma

Recruiting
N/A
100
Europe
Bortezomib-bendamustine-melphalan, High-dose melphalan
Uppsala University, Uppsala County Council, Sweden, Dalarna County Council, Sweden
Myeloma Multiple
03/25
11/25
Schalling, Ellika
MIRAA, NCT04957225: - Implementation of Intensive Rehabilitation of Aphasia and/or Apraxia of Speech in Swedish Healthcare

Completed
N/A
25
Europe
MIRAA (Multimodal Intensive Rehabilitation of Aphasia and Apraxia of speech), Modified ICAP (Intensive Comprehensive Aphasia Program)
Karolinska Institutet
Aphasia, Apraxia of Speech, Stroke
12/22
12/22
NCT04604444: Changes in Neuroplasticity Following Intensive Rehabilitation of Aphasia and/or Apraxia of Speech

Recruiting
N/A
30
Europe
Multimodal Intensive Rehabilitation of Aphasia and Apraxia of Speech
Karolinska Institutet, University of Malaga
Aphasia, Apraxia of Speech, Dysarthria
12/26
12/27
Schütz, Marika
NCT04604444: Changes in Neuroplasticity Following Intensive Rehabilitation of Aphasia and/or Apraxia of Speech

Recruiting
N/A
30
Europe
Multimodal Intensive Rehabilitation of Aphasia and Apraxia of Speech
Karolinska Institutet, University of Malaga
Aphasia, Apraxia of Speech, Dysarthria
12/26
12/27
Cherif, Honar
NCT06245629: Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma

Recruiting
N/A
100
Europe
Bortezomib-bendamustine-melphalan, High-dose melphalan
Uppsala University, Uppsala County Council, Sweden, Dalarna County Council, Sweden
Myeloma Multiple
03/25
11/25
Silfverberg, Thomas
NCT06245629: Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma

Recruiting
N/A
100
Europe
Bortezomib-bendamustine-melphalan, High-dose melphalan
Uppsala University, Uppsala County Council, Sweden, Dalarna County Council, Sweden
Myeloma Multiple
03/25
11/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Carlson, Kristina
NCT04067180: Randomized Clinical Study Assessing Haplo vs. URD in AML

Terminated
N/A
18
Europe, Canada, RoW
allogeneic stem cell transplantation with a haplo-identical family donor graft, allogeneic stem cell transplantation with a matched unrelated donor graft
Karolinska Institutet, Skane University Hospital, Uppsala University Hospital, University Hospital, Linkoeping, University Hospital, Umeå, Sahlgrenska University Hospital, Sweden, Oslo University Hospital, St. Petersburg State Pavlov Medical University, Princess Margaret Hospital, Canada, Medical University of Vienna
Acute Myeloid Leukemia
08/22
08/22
NCT06245629: Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma

Recruiting
N/A
100
Europe
Bortezomib-bendamustine-melphalan, High-dose melphalan
Uppsala University, Uppsala County Council, Sweden, Dalarna County Council, Sweden
Myeloma Multiple
03/25
11/25
Schalling, Ellika
MIRAA, NCT04957225: - Implementation of Intensive Rehabilitation of Aphasia and/or Apraxia of Speech in Swedish Healthcare

Completed
N/A
25
Europe
MIRAA (Multimodal Intensive Rehabilitation of Aphasia and Apraxia of speech), Modified ICAP (Intensive Comprehensive Aphasia Program)
Karolinska Institutet
Aphasia, Apraxia of Speech, Stroke
12/22
12/22
NCT04604444: Changes in Neuroplasticity Following Intensive Rehabilitation of Aphasia and/or Apraxia of Speech

Recruiting
N/A
30
Europe
Multimodal Intensive Rehabilitation of Aphasia and Apraxia of Speech
Karolinska Institutet, University of Malaga
Aphasia, Apraxia of Speech, Dysarthria
12/26
12/27
Schütz, Marika
NCT04604444: Changes in Neuroplasticity Following Intensive Rehabilitation of Aphasia and/or Apraxia of Speech

Recruiting
N/A
30
Europe
Multimodal Intensive Rehabilitation of Aphasia and Apraxia of Speech
Karolinska Institutet, University of Malaga
Aphasia, Apraxia of Speech, Dysarthria
12/26
12/27
Cherif, Honar
NCT06245629: Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma

Recruiting
N/A
100
Europe
Bortezomib-bendamustine-melphalan, High-dose melphalan
Uppsala University, Uppsala County Council, Sweden, Dalarna County Council, Sweden
Myeloma Multiple
03/25
11/25
Silfverberg, Thomas
NCT06245629: Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma

Recruiting
N/A
100
Europe
Bortezomib-bendamustine-melphalan, High-dose melphalan
Uppsala University, Uppsala County Council, Sweden, Dalarna County Council, Sweden
Myeloma Multiple
03/25
11/25

Download Options